View Older Stories View More Recent Stories

Jul 17, 2025 08:02AM ENHERTU plus pertuzumab gets FDA breakthrough therapy designation
Jul 14, 2025 07:01AM AstraZeneca drug meets goals in hypertension trial
Jul 3, 2025 10:17AM Summit Therapeutics (SMMT) Is Said In Talks For $15 Billion Partnership With Astra (AZN) - Bloomberg
Jul 1, 2025 10:44AM AstraZeneca stock rises amid reports CEO favors US listing move
Jul 1, 2025 10:35AM AstraZeneca (AZN) CEO Wants To Move Listing To US - The Times
Jun 23, 2025 04:04PM AstraZeneca (AZN) says Datroway approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
Jun 13, 2025 04:56AM AstraZeneca (AZN) enters strategic collaboration with CSPC Pharmaceuticals focused on AI-enabled research
Jun 12, 2025 07:53AM UBS identifies stock winners amid structural growth tailwinds
Jun 2, 2025 08:06AM Daiichi Sankyo, AstraZeneca (AZN): ENHERTU Plus Pertuzumab Reduced the Risk of Disease Progression or Death
Jun 2, 2025 08:05AM AstraZeneca (AZN) Reports ENHERTU plus pertuzumab reduced the risk of disease progression or death by 44% vs. THP
May 30, 2025 05:01AM Citizens JMP: Standard of Care Modifying Regimens at ASCO 2025
May 29, 2025 04:30PM Danaher (DHR) Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine
May 20, 2025 11:04AM FDA Mandates Trials For Covid Boosters For Healthy Kids, Adults - NEJM
May 19, 2025 12:37PM AstraZeneca (AZN) reveals positive results from BATURA Phase 3b trial
May 19, 2025 12:23PM Airsupra shows significant improvement in asthma treatment, AstraZeneca (AZN) reveals
May 9, 2025 07:00AM AstraZeneca (AZN) Reports IMFINZI regimen demonstrated statistically significant and clinically meaningful improvement in disease-free survival for high-risk non-muscle-invasive bladder cancer in POTO
May 2, 2025 08:30AM Bernstein explains why share price rally in this pharma stock should continue
May 2, 2025 07:00AM AstraZeneca (AZN) reports BREZTRI met primary endpoints in KALOS and LOGOS Phase III trials in asthma
Apr 29, 2025 03:31AM AstraZeneca (AZN) Tops Q1 EPS by 139c
Apr 28, 2025 12:01PM SOPHiA GENETICS (SOPH) Announces Expanded Collaboration with AstraZeneca to Accelerate Liquid Biopsy Testing Globally from AACR
Apr 23, 2025 08:00AM Tempus AI (TEM) Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology
Apr 22, 2025 06:00AM AstraZeneca is due to report next week. Here's what analysts expect
Apr 16, 2025 10:14AM BNP Paribas Exane Starts AstraZeneca (AZN:LN) (AZN) at Outperform
Apr 9, 2025 09:19AM Pharma stocks slide after Trump signals tariffs on sector
Apr 4, 2025 06:23AM AstraZeneca (AZN) Announces ENHERTU Approved in the EU as First HER2 Directed Therapy for Patients with HR Positive, HER2 Low or HER2 Ultralow Metastatic Breast Cancer
Mar 31, 2025 12:00PM AstraZeneca (AZN) reports that AZD0780 demonstrated significant LDL cholesterol reduction in PURSUIT Phase IIb trial
Mar 31, 2025 07:06AM AstraZeneca (AZN): IMFINZI approved in the US as first and only perioperative immunotherapy for patients with muscle-invasive bladder cancer
Mar 28, 2025 04:54AM Goldman Sachs on AstraZeneca (AZN): 'we are positive on the long-term outlook and like the company's strategy'
Mar 28, 2025 02:42AM AstraZeneca (AZN:LN) (AZN) PT Raised to GBP151.30 at Goldman Sachs
Mar 26, 2025 09:45AM Truist Weighs In on Obesity: 'Catalyst-Rich 2025 Ahead in a Growing Competitive Landscape'
Mar 21, 2025 07:22AM AstraZeneca (AZN) and Harbour BioMed Enter Global Strategic Collaboration to Discover and Develop Next-Generation Therapeutic Antibodies
Mar 21, 2025 07:03AM AstraZeneca (AZN) to invest $2.5B in new global strategic R&D centre, biotech agreements and manufacturing in Beijing
Mar 19, 2025 12:13PM TD Cowen Highlights AstraZeneca's (AZN) 'Attractive Valuation'; Stock Named Europe Best Ideas
Mar 17, 2025 08:14AM AstraZeneca (AZN) to acquire EsoBiotec
Mar 7, 2025 07:01AM AstraZeneca (AZN): IMFINZI (durvalumab)-based regimen demonstrated statistically significant and clinically meaningful improvement
Mar 3, 2025 08:00AM These 5 stocks are latest additions to Goldman's 'European Conviction List - Directors’ Cut' list
Feb 28, 2025 08:01AM AstraZeneca (AZN) reports ENHERTU Recommended for Approval in the EU by CHMP
Feb 26, 2025 07:00AM AstraZeneca (AZN) reports Camizestrant demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival in 1st-line advanced HR-positive breast cancer w
Feb 21, 2025 04:00PM FINAL REMINDER AZN DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts AstraZeneca PLC Investors to Participate in the Class Action Lawsuit
Feb 20, 2025 07:30PM AZN DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN
Feb 20, 2025 04:00PM FINAL AZN DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds AstraZeneca PLC Investors to Join the Class Action Lawsuit
Feb 20, 2025 03:24PM AZN FINAL DEADLINE ALERT: AstraZeneca (AZN) Investors with Losses Encouraged to Contact Hagens Berman Before Feb. 21, 2025 Deadline in Securities Class Action
Feb 20, 2025 06:33AM FibroGen (FGEN) Sells FibroGen China to AstraZeneca (AZN) for $160M
Feb 18, 2025 05:42PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Feb 18, 2025 01:27PM AstraZeneca (AZN) Hit With US Class Action Lawsuit Over China Regulatory Probes - FT
Feb 18, 2025 01:05PM AZN DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN
Feb 17, 2025 01:14PM AZN DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN
Feb 17, 2025 11:29AM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
Feb 16, 2025 12:21PM AZN DEADLINE ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by th
Feb 15, 2025 08:16AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AstraZeneca
View More Recent Stories View Older Stories